MCCRP's core research components are the Center for Prostate Disease Research (CPDR), Clinical Breast Care Project (CBCP), and the GYN COE. MCCRP also funds and operates the DoD's precision oncology research program known as APOLLO (Applied Proteogenomics Organizational Learning and Outcomes), whereby we perform full DNA sequencing and RNA sequencing on service member's cancer specimens at The American Genome Center at USU and full proteomics analyses at the MCCRP Protemic Lab at INOVA, Fairfax. MCCRP also is a member of the nationwide consortium known as ORIEN, and we collaborate with experts at all member centers.

The MCCRP enhances the mission of the Department of Surgery at USUHS by providing critical research opportunities for students, faculty, and a myriad of other post-doctoral and PhD employees of the entire USUHS community. In the past 4 years, MCCRP has provided over $13 million to its intramural (USUHS-WR only) research program that has directly funded over two dozen researchers at USUHS, resulting in high-quality journal manuscripts and subsequent extramural grant awards to investigators based on the preliminary data from the intramural MCCRP funding. MCCRP research also is a key element in the Department of Surgery’s leadership across USUHS in the critical metric of research publications, presentations, posters, abstracts, and acceptances in national forums, promulgating the banner of USUHS and its DOS in the national arena. Moreover, from 2015 through 2017, MCCRP’s Metastatic Cancer Task Force (provisioned by Congress) trained over a dozen volunteer USUHS medical students to perform critical literature reviews of cancer by our Epidemiology team, and those students then presented their work at the final Metastatic Cancer Task Force Operational Meeting which was subsequently published in the Final Report to Congress. So, MCCRP has and does provide a myriad of opportunities to all faculty and students at USUHS.